PB RCPsych Publications
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
British Journal of Psychiatry Advances in Psychiatric Treatment All RCPsych Journals
QUICK SEARCH:   [advanced]


     

Psychiatric Bulletin (2006) 30: 76. doi: 10.1192/pb.30.2.76-a
© 2006 The Royal College of Psychiatrists
This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Euba, R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Euba, R.
Psychiatric Bulletin (2006) 30: 76
© 2006 The Royal College of Psychiatrists

Correspondence

Cholinesterase inhibitors and Alzheimer’s disease

Rafael Euba, Consultant and Senior Lecturer in Old Age Psychiatry

Memorial Hospital, Shooters Hill, London SE18 3RZ, e-mail: Rafael.Euba{at}oxleas.nhs.uk

Simpson et al (Psychiatric Bulletin, November 2005, 29, 410-412) state in their audit of the use of cholinesterase inhibitors that stopping these drugs in the latest stages of dementia ‘is poor clinical practice and likely to have adverse outcomes’. They base this opinion on the fact that many of the patients in their sample deteriorated or died after their memory enhancers were discontinued when their Mini-Mental State Examination scores fell below 12. The authors acknowledge that this high death rate could be because the patients who deteriorated or died were probably the most physically ill. In fact, this would be the simplest and most likely explanation. Therefore, the conclusion that stopping these drugs in the advanced stages of dementia constitutes poor clinical practice is really unfounded and could only be supported after the hypothesis is tested successfully in a controlled trial.





This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Euba, R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Euba, R.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
British Journal of Psychiatry Advances in Psychiatric Treatment All RCPsych Journals